Bvf Inc Tyra Biosciences, Inc. Call Options Transaction History
Bvf Inc
- $2.54 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding TYRA
# of Institutions
119Shares Held
59.8MCall Options Held
0Put Options Held
0-
Ra Capital Management, L.P. Boston, MA12.2MShares$129 Million2.55% of portfolio
-
Alta Partners Management Company, L.P. Jackson, WY4.08MShares$43.3 Million93.82% of portfolio
-
Nextech Invest Ag4.06MShares$43 Million10.51% of portfolio
-
Nextech Invest, Ltd. Zurich, V84.06MShares$43 Million7.35% of portfolio
-
Canaan Partners Xi LLC Menlo Park, CA3.61MShares$38.2 Million96.23% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $445M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...